Wells Fargo & Company MN Cuts Holdings in Abrdn Healthcare Investors (NYSE:HQH)

Wells Fargo & Company MN decreased its position in shares of Abrdn Healthcare Investors (NYSE:HQH) by 56.4% in the fourth quarter, HoldingsChannel reports. The firm owned 3,868 shares of the financial services provider’s stock after selling 5,009 shares during the quarter. Wells Fargo & Company MN’s holdings in Abrdn Healthcare Investors were worth $62,000 at the end of the most recent reporting period.

Several other institutional investors and hedge funds also recently added to or reduced their stakes in the stock. Raymond James Financial Inc. bought a new stake in shares of Abrdn Healthcare Investors during the fourth quarter valued at approximately $15,049,000. Wolverine Asset Management LLC purchased a new position in Abrdn Healthcare Investors during the fourth quarter valued at approximately $2,196,000. LPL Financial LLC grew its holdings in Abrdn Healthcare Investors by 65.3% in the fourth quarter. LPL Financial LLC now owns 282,020 shares of the financial services provider’s stock worth $4,526,000 after purchasing an additional 111,383 shares during the last quarter. Absolute Investment Advisers LLC purchased a new position in Abrdn Healthcare Investors in the fourth quarter worth $1,786,000. Finally, Oppenheimer & Co. Inc. grew its holdings in Abrdn Healthcare Investors by 94.6% in the fourth quarter. Oppenheimer & Co. Inc. now owns 174,268 shares of the financial services provider’s stock worth $2,797,000 after purchasing an additional 84,731 shares during the last quarter. Hedge funds and other institutional investors own 32.60% of the company’s stock.

Abrdn Healthcare Investors Stock Down 1.9%

NYSE HQH opened at $15.33 on Wednesday. The firm’s fifty day simple moving average is $15.83 and its two-hundred day simple moving average is $16.84. Abrdn Healthcare Investors has a 12-month low of $13.77 and a 12-month high of $19.79.

Abrdn Healthcare Investors Profile

Abrdn Healthcare Investors is a closed-ended equity mutual fund launched and managed by abrdn Inc The fund invests in public equity markets across the globe. It seeks to invest in stocks of companies operating in the healthcare sector, including the biotechnology, medical devices, and pharmaceuticals industries.